Dalila Costa

Dalila Costa currently serves as Associate Director of Clinical Development Operations at Gilead Sciences since January 2023. Prior to this role, Dalila was Indication Team Lead at Amgen, overseeing operational delivery of Early Development Oncology programs, and previously held positions including Lead Global Early Drug Development Manager, contributing to the execution of innovative oncology trials for LUMAKRAS™. Dalila's extensive experience includes roles at PPD as Senior Clinical Trial Manager and Clinical Team Manager, managing both early and late-phase clinical trials and leading teams. Dalila's career began at Wyeth and Eurotrials, progressing through various roles in clinical research. Dalila earned a degree from Pontifícia Universidade Católica de Campinas and is currently pursuing an MBA at Golden Gate University.